Table 1. Clinical characteristics and laboratory findings of analyzed subjects.
| Survival (n=48) | Cardiovascular mortality (n=7) | P value | |
|---|---|---|---|
| Demographic data | |||
| Age (years) | 65.6±13.1 | 74.4±8.4 | 0.089 |
| Sex (M/F) | 33∶15 | 6∶1 | 0.660 |
| STEMI/NSTEMI | 26∶22 | 2∶5 | 0.252 |
| Extent of CAD (1-VD/2-VD/3-VD) (%) | 22.7/40.9/36.4 | 0/28.6/71.4 | 0.163 |
| Infarct-related arteries (LM/LAD/LCx/RCA) (%) | 0/48.8/14.6/36.6 | 20.0/40.0/0/40.0 | 0.029* |
| Mode of treatment (PCI/CABG/medical) (%) | 87.5/0/12.5 | 57.1/14.3/28.6 | 0.013* |
| Door-to-balloon time (minutes; in STEMI) | 155.0±470.2 | 70.0±22.6 | 0.804 |
| TIMI flow before PCI (0/1/2/3) | 19/2/4/21 | 2/0/1/4 | 0.820 |
| TIMI flow after PCI (0/1/2/3) | 1/0/0/45 | 1/0/1/5 | 0.009* |
| Laboratory findings | |||
| Hemoglobin (g/dl) | 13.5±2.4 | 11.3±1.6 | 0.021* |
| BUN (mg/dl) | 18.5±7.3 | 32.2±10.1 | <0.001* |
| Cr (mg/dl) | 1.1±0.5 | 3.8±2.2 | 0.019* |
| Total cholesterol (mg/dl) | 155.8±41.5 | 124.7±43.4 | 0.071 |
| Triglyceride (mg/dl) | 109.7±62.4 | 88.9±41.7 | 0.398 |
| HDL cholesterol (mg/dl) | 39.7±11.2 | 32.0±9.6 | 0.093 |
| LDL cholesterol (mg/dl) | 93.8±39.5 | 71.0±29.2 | 0.149 |
| hsCRP (mg/l) | 33.2±55.6 | 105.5±87.7 | 0.073 |
| Initial CK-MB (ng/ml) | 27.9±68.1 | 41.9±57.7 | 0.607 |
| Peak CK-MB (ng/ml) | 141.0±162.5 | 69.4±63.9 | 0.257 |
| Initial Troponin-T (ng/ml) | 0.9±2.7 | 2.0±3.6 | 0.345 |
| Peak Troponin-T (ng/ml) | 1.4±3.2 | 4.0±4.4 | 0.173 |
| NT-proBNP (pg/ml) | 1613.8±3506.2 | 18591.7±15332.7 | 0.026* |
| Echocardiographic data | |||
| LVEF (%) | 53.7±13.6 | 41.4±10.8 | 0.027* |
| LVEDD (mm) | 50.0±5.2 | 53.3±7.3 | 0.147 |
| LVESD (mm) | 35.0±5.9 | 41.7±8.3 | 0.011* |
| LA Vol. index (ml/m2) | 28.2±10.9 | 37.4±21.0 | 0.291 |
Abbreviations: BUN, blood urea nitrogen; CABG, coronary artery bypass surgery; CAD, coronary artery disease; CK-MB, creatine kinase MB; Cr, creatinine; HDL, high-density lipoprotein; hsCRP, high sensitivity C-reactive protein; LAD, left anterior descending artery; LA Vol. index, left atrial volume index; LCx, left circumflex artery; LDL, low-density lipoprotein; LM, left main artery; LVEDD, left ventricular end diastolic dimension; LVEF, left ventricular ejection fraction; LVESD, left ventricular end systolic dimension; NSTEMI, non-ST-segment elevation myocardial infarction; NT-proBNP, N-terminal pro-brain natriuretic peptide; PCI, percutaneous coronary intervention; RCA, right coronary artery; STEMI, ST-segment elevation myocardial infarction; TIMI, thrombolysis in myocardial infarction; VD, vessel disease.
Values are presented as a %, or mean±s.d.
P<0.05 is considered significant.